Papp L Roy & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History

Papp L Roy & Associates

$772 Million
Q1 2025

A detailed history of Papp L Roy & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Papp L Roy & Associates holds 146,477 shares of XBI stock, worth $12.4 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares

146,477

Previous 151,007 3.0%

Holding current value

$12.4 Million

Previous $13.6 Million 9.1%

% of portfolio

1.6%

Previous 1.68%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	SELL	$81.1 - $94.7 $367,383 - $428,991	-4,530 Reduced 3.0%	146,477 $12.4 Million
Q4 2024 Jan 29, 2025	SELL	$89.81 - $104.0 $323,944 - $375,128	-3,607 Reduced 2.33%	151,007 $13.6 Million
Q3 2024 Oct 24, 2024	SELL	$90.87 - $102.43 $105,227 - $118,613	-1,158 Reduced 0.74%	154,614 $15.3 Million
Q2 2024 Jul 24, 2024	SELL	$82.22 - $94.12 $241,480 - $276,430	-2,937 Reduced 1.85%	155,772 $14.4 Million
Q1 2024 Apr 15, 2024	SELL	$87.05 - $102.89 $868,236 - $1.03 Million	-9,974 Reduced 5.91%	158,709 $15.1 Million
Q4 2023 Jan 19, 2024	SELL	$64.12 - $90.86 $842,536 - $1.19 Million	-13,140 Reduced 7.23%	168,683 $15.1 Million
Q3 2023 Oct 18, 2023	SELL	$71.88 - $85.76 $541,472 - $646,030	-7,533 Reduced 3.98%	181,823 $13.3 Million
Q2 2023 Jul 17, 2023	SELL	$75.38 - $90.23 $67,842 - $81,207	-900 Reduced 0.47%	189,356 $15.8 Million
Q1 2023 May 05, 2023	SELL	$73.13 - $91.97 $541,893 - $681,497	-7,410 Reduced 3.75%	190,256 $14.5 Million
Q4 2022 Jan 17, 2023	SELL	$76.72 - $85.66 $401,705 - $448,515	-5,236 Reduced 2.58%	197,666 $0
Q3 2022 Oct 21, 2022	SELL	$75.06 - $94.9 $356,384 - $450,585	-4,748 Reduced 2.29%	202,902 $16.1 Million
Q2 2022 Aug 02, 2022	SELL	$62.81 - $96.09 $39,947 - $61,113	-636 Reduced 0.31%	207,650 $15.4 Million
Q1 2022 May 06, 2022	SELL	$81.07 - $115.44 $98,986 - $140,952	-1,221 Reduced 0.58%	208,286 $18.7 Million
Q4 2021 Feb 11, 2022	BUY	$108.77 - $134.15 $480,002 - $592,003	4,413 Added 2.15%	209,507 $23.5 Million
Q3 2021 Nov 09, 2021	BUY	$118.69 - $138.49 $799,733 - $933,145	6,738 Added 3.4%	205,094 $25.8 Million
Q2 2021 Aug 09, 2021	BUY	$122.48 - $139.69 $2.35 Million - $2.68 Million	19,195 Added 10.71%	198,356 $26.9 Million
Q1 2021 May 06, 2021	SELL	$129.36 - $173.99 $5.61 Million - $7.55 Million	-43,401 Reduced 19.5%	179,161 $24.3 Million
Q4 2020 Feb 10, 2021	SELL	$110.36 - $151.14 $138,170 - $189,227	-1,252 Reduced 0.56%	222,562 $31.3 Million
Q3 2020 Nov 13, 2020	SELL	$103.87 - $120.36 $63,983 - $74,141	-616 Reduced 0.27%	223,814 $24.9 Million
Q2 2020 Aug 11, 2020	BUY	$73.26 - $114.17 $57,509 - $89,623	785 Added 0.35%	224,430 $25.1 Million
Q1 2020 May 05, 2020	BUY	$65.95 - $98.35 $217,964 - $325,046	3,305 Added 1.5%	223,645 $17.3 Million
Q4 2019 Feb 14, 2020	BUY	$74.65 - $98.46 $385,641 - $508,644	5,166 Added 2.4%	220,340 $21 Million
Q3 2019 Nov 04, 2019	BUY	$76.25 - $83.86 $581,253 - $639,264	7,623 Added 3.67%	215,174 $16.4 Million
Q2 2019 Aug 14, 2019	SELL	N/A	-193,996 Closed	0 $0
Q1 2019 May 09, 2019	BUY	N/A	12,773 Added 7.05%	193,996 $17.6 Million
Q4 2018 Feb 13, 2019	BUY	N/A	1,202 Added 0.67%	181,223 $13 Million
Q3 2018 Nov 13, 2018	SELL	N/A	-6,518 Reduced 3.49%	180,021 $17.3 Million
Q2 2018 Aug 09, 2018	SELL	N/A	-1,750 Reduced 0.93%	186,539 $17.8 Million
Q1 2018 May 15, 2018	BUY	N/A	4,032 Added 2.19%	188,289 $16.5 Million
Q4 2017 Feb 06, 2018	SELL	N/A	-1,748 Reduced 0.94%	184,257 $15.6 Million
Q3 2017 Nov 06, 2017	BUY	N/A	186,005	186,005 $16.1 Million

Others Institutions Holding XBI

# of Institutions

844

Shares Held

108M

Call Options Held

17.7M

Put Options Held

28.5M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.

Account

Papp L Roy & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History